Moderna files for authorization of COVID vaccine in teens ages 12-17
Moderna has filed for emergency use authorization with the FDA for its COVID-19 vaccine for use in US teens ages 12 to 17.
“We are pleased to announce that we have submitted for an emergency use authorization for our COVID-19 vaccine with the FDA for use in adolescents in the United States,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents.”
Moderna’s COVID vaccine is currently authorized for people ages 18 and older.
Last month,...